Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mucosal Microbiota and Immune Response to Intranasal LAIV in Children and Adolescents
NCT06609811Phase 4Completed
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Sep 2024
- Primary completion
- Dec 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of live attenuated influenza vaccine in influenza, sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Started Sep 2024; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT06609811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06609811.